Filing metadata

Accession number
0000899243-22-011594
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Mar 18, 2022
Reporting period
Mar 16, 2022
Description
Insider transaction

Explore SEC Filings Hub